Africa: Morocco's First Homegrown PCR Test for Mpox Gets Africa CDC Nod

12 November 2024
Africa Centres for Disease Control and Prevention (Addis Ababa)

Addis Ababa, Ethiopia — Africa Centres for Disease Control and Prevention through its Diagnostic Advisory Committee (DAC) has recommended the first locally manufactured Real-Time PCR test for mpox from Morocco. Africa CDC's approval underscores the test's reliability and efficacy, potentially boosting Morocco's role in global health initiatives.

This major milestone is in line with the African Union's continental effort to strengthen the self-sufficiency of African public health systems towards enhancing the continent's efficiency in preparedness and response to disease threats.

It has been 93 days since the declaration of the mpox outbreak as a Public Health Emergency of Continental Security by the Africa CDC and a Public Health Emergency of International Concern and World Health Organization (WHO). Within this 100-day mission period, a joint Africa CDC/WHO continental plan was launched.

Africa CDC has supported Member States through the continental plan. It procured and delivered PCR and genome sequencing test kits, GeneXpert cartridges. It also trained them on specimen collection and transportation, biosafety and biosecurity, and molecular testing for mpox. Africa CDC's DAC offered crucial guidance to Member States, recommending specific RT-PCR tests for procurement and use - an advisory support that proved invaluable for national testing strategies.

Africa CDC and AUDA NEPAD jointly established the DAC as a quality mechanism to guide the selection, evaluation, validation, verification, and adoption of laboratory diagnostic technologies. It also facilitates data sharing. During this mpox emergency, Africa CDC has worked through the DAC to publish two editions of a recommended list of RT-PCR tests for mpox. Tests on the list have undergone a stringent, systematic process involving an independent review of the available evidence. The tests must fulfill key criteria set by the DAC based on the WHO Target Product Profile for mpox diagnostics.

The third edition of recommended list was published on 12 November 2024. The edition includes one locally manufactured PCR detection kit (UM6P-MAScIR MPOX qPCR 1.0), manufactured by Moldiag, Morocco. The DAC reviewed the evidence about this test based on set criteria including independent evaluation data from the National Institute for Biomedical Research (INRB) in the Democratic Republic of Congo (DRC) and concluded that it fulfilled all the major criteria. This is a major achievement in the mpox response. The Chief Executive Officer of Moldiag, Ms Nawal Chraibi, said that: "At Moldiag, we are dedicated to supporting Africa's health resilience through the development of locally manufactured diagnostic tools. We believe that strengthening local production is key to empowering the continent in its epidemic preparedness and response, allowing us to respond rapidly and effectively to public health challenges. We are proud to align with Africa CDC's vision of a self-sufficient and health-secure Africa."

Local manufacturing of diagnostics constitutes one of the five strategic pillars of the framework for action, "A New Public Health Order for Africa" launched by the African Union through Africa CDC. Dr. Jean Kaseya, Director General of Africa CDC said, Africa CDC is leading an ambitious but very critical continental agenda on local manufacturing of medical counter measures, a critical element for the health security of the continent. "The PCR test kit for mpox, locally manufactured in Morocco, which passed through stringent criteria, recommended by our DAC to be shortlisted is testament that quality medical counter measures including diagnostics can be availed locally during outbreaks. I would like to congratulate Morocco for this outstanding achievement and encourage African Union Member States to consider the use of this testing solution as they continue responding to the mpox outbreak."

This crucial step will inspire local makers of diagnostics and other epidemic related products. Africa CDC is committed to work with these manufacturers and key stakeholders to make necessary medical products are available for the continent's health security.

For media enquiries please contact:

About Africa CDC: The Africa Centres for Disease Control and Prevention (Africa CDC) is a public health agency of the African Union. It is autonomous and supports member states in strengthening health systems. It also helps improve disease surveillance, emergency response, and disease control. Learn more at: http://www.africacdc.org and connect with us on LinkedIn, Twitter, Facebook and YouTube

Read the original article on Africa CDC.

Tagged:
Copyright © 2024 Africa Centres for Disease Control and Prevention. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 600 reports a day from more than 110 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.